Suppr超能文献

头孢哌酮及头孢哌酮-舒巴坦对碳青霉烯类耐药菌的体外活性及……(原文此处不完整)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant and .

作者信息

Lai Chih-Cheng, Chen Chi-Chung, Lu Ying-Chen, Chuang Yin-Ching, Tang Hung-Jen

机构信息

Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.

Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.

出版信息

Infect Drug Resist. 2018 Dec 20;12:25-29. doi: 10.2147/IDR.S181201. eCollection 2019.

Abstract

BACKGROUND

This study aimed to investigate the in vitro activity of cefoperazone-sulbactam against carbapenem-resistant and , and to evaluate the antibiotic resistance mechanisms of these bacteria.

MATERIALS AND METHODS

In total, 21 isolates of carbapenem-resistant and 15 isolates of carbapenem-resistant with different pulsed-field gel electrophoresis types were collected for assessment of the in vitro antibacterial activities of cefoperazone and cefoperazone-sulbactam and the associated resistance mechanisms of the bacteria.

RESULTS

For carbapenem-resistant , the minimum inhibitory concentration (MIC) value and antibiotic susceptibility rate were similar for cefoperazone and cefoperazone-sulbactam (at 1:1 and 2:1 ratios). In contrast, for carbapenem-resistant , the MIC values, including the MIC range, MIC that inhibited 50% of isolates (MIC) and MIC that inhibited 90% of isolates (MIC), were reduced after treatment with sulbactam and cefoperazone. We screened resistance genes, including VIM-2, OXA-2 and OXA-10, in 21 carbapenem-resistant isolates. Only one (4.8%) of the isolates showed expression of VIM-2, and neither the OXA-2 nor the OXA-10 gene was detected. However, 20 (95.2%) isolates among the carbapenem-resistant isolates selected for oprD sequencing showed the phenomenon of nucleotide substitution or deletion. Among 15 carbapenem-resistant isolates, we found that ten (66.7%) isolates had concomitant expression of the OXA-23 and ISAba1-OXA-23 genes, and six (40.0%) isolates had expression of the OXA-24-like gene. All 15 isolates had OXA-51-like gene expression, and only 1 (6.7%) isolate had ISAba1-OXA-51-like gene expression. None of the isolates contained the IMP-1, IMP-8, KPC, NDM, VIM-1 or OXA-48 genes.

CONCLUSION

The in vitro antibacterial activity of cefoperazone against carbapenem-resistant can be enhanced by adding sulbactam to cefoperazone, but the addition does not affect carbapenem-resistant . This significant difference can be explained by the different resistance mechanisms of carbapenem-resistant and .

摘要

背景

本研究旨在调查头孢哌酮-舒巴坦对耐碳青霉烯类[细菌名称1]和[细菌名称2]的体外活性,并评估这些细菌的耐药机制。

材料与方法

共收集了21株耐碳青霉烯类[细菌名称1]分离株和15株具有不同脉冲场凝胶电泳类型的耐碳青霉烯类[细菌名称2]分离株,以评估头孢哌酮和头孢哌酮-舒巴坦的体外抗菌活性以及细菌的相关耐药机制。

结果

对于耐碳青霉烯类[细菌名称1],头孢哌酮和头孢哌酮-舒巴坦(1:1和2:1比例)的最低抑菌浓度(MIC)值及抗生素敏感率相似。相比之下,对于耐碳青霉烯类[细菌名称2],用舒巴坦和头孢哌酮处理后,MIC值(包括MIC范围、抑制50%分离株的MIC(MIC50)和抑制90%分离株的MIC(MIC90))降低。我们在21株耐碳青霉烯类[细菌名称1]分离株中筛选了耐药基因,包括VIM-2、OXA-2和OXA-10。仅1株(4.8%)分离株显示VIM-2表达,未检测到OXA-2和OXA-10基因。然而,在选择进行oprD测序的耐碳青霉烯类[细菌名称1]分离株中,20株(95.2%)出现核苷酸取代或缺失现象(此处原文表述有误,oprD是针对铜绿假单胞菌的外膜孔蛋白基因,原文前面说的是耐碳青霉烯类[细菌名称1],这里推测可能是[细菌名称1]为铜绿假单胞菌,若不是请根据实际情况调整)。在15株耐碳青霉烯类[细菌名称2]分离株中,我们发现10株(66.7%)分离株同时表达OXA-23和ISAba1-OXA-23基因,6株(40.0%)分离株表达OXA-24样基因。所有15株分离株均有OXA-51样基因表达,仅1株(6.7%)分离株有ISAba1-OXA-51样基因表达。所有分离株均未含有IMP-1、IMP-8、KPC、NDM、VIM-1或OXA-48基因。

结论

头孢哌酮对耐碳青霉烯类[细菌名称1]的体外抗菌活性可通过向头孢哌酮中添加舒巴坦来增强,但添加后对耐碳青霉烯类[细菌名称2]无影响。这种显著差异可由耐碳青霉烯类[细菌名称1]和[细菌名称2]不同的耐药机制来解释。

相似文献

1
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant and .
Infect Drug Resist. 2018 Dec 20;12:25-29. doi: 10.2147/IDR.S181201. eCollection 2019.
2
Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms.
Infect Drug Resist. 2018 Sep 11;11:1441-1445. doi: 10.2147/IDR.S175257. eCollection 2018.
4
Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).
Springerplus. 2016 Aug 9;5(1):1308. doi: 10.1186/s40064-016-2986-7. eCollection 2016.
7
The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
J Microbiol Immunol Infect. 2018 Apr;51(2):207-213. doi: 10.1016/j.jmii.2017.08.026. Epub 2017 Oct 6.
8
Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against .
Infect Drug Resist. 2021 Sep 28;14:3971-3977. doi: 10.2147/IDR.S332160. eCollection 2021.
10
In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
J Glob Antimicrob Resist. 2022 Sep;30:445-450. doi: 10.1016/j.jgar.2022.05.011. Epub 2022 May 23.

引用本文的文献

2
Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies.
Appl Biochem Biotechnol. 2025 Feb 18. doi: 10.1007/s12010-025-05182-8.
3
The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model.
Front Pharmacol. 2025 Jan 3;15:1505653. doi: 10.3389/fphar.2024.1505653. eCollection 2024.
8
Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012-2021).
Heliyon. 2024 Jun 19;10(13):e33114. doi: 10.1016/j.heliyon.2024.e33114. eCollection 2024 Jul 15.
10
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli Bacteremia.
Infect Dis Ther. 2022 Oct;11(5):1853-1867. doi: 10.1007/s40121-022-00672-2. Epub 2022 Jul 22.

本文引用的文献

1
Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms.
Infect Drug Resist. 2018 Sep 11;11:1441-1445. doi: 10.2147/IDR.S175257. eCollection 2018.
2
The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms.
J Microbiol Immunol Infect. 2018 Apr;51(2):207-213. doi: 10.1016/j.jmii.2017.08.026. Epub 2017 Oct 6.
5
Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance.
J Appl Microbiol. 2016 Mar;120(3):619-29. doi: 10.1111/jam.13037.
6
Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii.
Front Microbiol. 2015 Mar 25;6:231. doi: 10.3389/fmicb.2015.00231. eCollection 2015.
8
Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections.
J Microbiol Immunol Infect. 2016 Feb;49(1):52-9. doi: 10.1016/j.jmii.2014.01.005. Epub 2014 Mar 21.
9
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Antimicrob Agents Chemother. 2010 May;54(5):2078-84. doi: 10.1128/AAC.01398-09. Epub 2010 Mar 1.
10
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
Antimicrob Agents Chemother. 2009 Aug;53(8):3579-81. doi: 10.1128/AAC.00072-09. Epub 2009 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验